The Montgomery County Economic Development Corporation (MCEDC) and its board are pleased to welcome Bill Tompkins as Chief Operating Officer. Bill brings to Montgomery County a strong corporate and trade association background, having served in multiple senior level roles for Fortune 500 and other organizations.
The hire is well known in the business community for her previous roles at local organizations.
Pappas Capital has raised $85.8 million toward a venture-capital fund, according to a filing with the SEC.
A. M. Pappas Life Science Ventures V attracted capital from 29 LPs.
Study participants will use emocha’s platform to video record themselves each day for 24 weeks as they take buprenorphine.
While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there, even for a few days, are becoming untenable for some.
As 9,000 official badge holders—alongside what could feel like three times as many unofficial attendees—swarmed downtown San Francisco for the annual J.P. Morgan Healthcare Conference, much of the opening small talk in the hastily bedless hotel suites-turned-meeting rooms began with, “Can you believe some of these prices?”
BIO, in partnership with the American Seed Trade Association (ASTA), is proud to announce today that we are launching Innovature, an initiative to engage people in a dialogue on the promise of innovation in food and agriculture and the tangible benefits it brings to our planet, our health, and our food.
The goal of Innovature is to grow awareness, acceptance and adoption of gene editing in food and agriculture, and seed positive ground for future innovations that address some of society’s most pressing challenges, such as climate change, hunger and sustainability.
Popper and Co., a strategy consulting and transaction advisory firm guiding medical technology and life sciences companies working on the leading-edge of diagnostics and patient management, announced today the addition of Vincent Linder, PhD and Gene Vivino to its growing team of industry and clinical senior advisors. Both Dr. Linder and Mr. Vivino provide strong industry knowledge and extensive operating experience, in addition to broad networks in both Europe and Asia.
To date, the conversation around CAR-T cell therapies in cancers has focused on the most visible considerations: efficacy, toxicity and cost. But while those factors are important, another one deserves equal consideration: manufacturing.
Join us for the January 23, 2019 for PATHFINDER INNOVATION PROGRAM
Learn more about:
Schedule
12:00 p.m – Networking Lunch
12:30 – 1:30 p.m. – Discussion with Q&A* – Tom Christiana, Partner – Aronson, LLC
1:30 – 4:00 p.m. – One-on-one Meetings**
RSVP by noon, January 22, at BHI@BioHealthInnovation.org
No charge to attend but pre-registration is required.*Attend in person (1 Church St, Rockville) or by videoconference**Attendance at discussion is required to participate in 1:1
Montgomery beat out Boston and the Philadelphia areas to win the project.
